IMC Chicago’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
IMC Chicago's GILD Position: Q3 2026 in Review
IMC Chicago reduced its Gilead Sciences (GILD) stake by 66% in Q3 2026, selling an estimated $2.15M and leaving 7,890 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #3712.
IMC Chicago first reported a position in GILD in Q4 2019 and has held it in 14 quarters since. The position peaked at $21.5M in Q4 2022. 1,465 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- IMC Chicago held 7,890 shares of Gilead Sciences worth $1.18M as of Q3 2026.
- IMC Chicago sold 15,326 Gilead Sciences shares in Q3 2026, an estimated $2.15M.
- Gilead Sciences made up ﹤0.01% of IMC Chicago's portfolio in Q3 2026, its #3712 holding.
- IMC Chicago first reported a position in Gilead Sciences in Q4 2019 and has held it in 14 quarters since.
- IMC Chicago's Gilead Sciences position peaked at $21.5M in Q4 2022.
- 1,465 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on IMC Chicago's 13F filing for Q3 2026, filed 5 Nov 2026.